Michael P. Ellenberger

Highly Selective Dopamine D₃ Receptor (D₃R) Antagonists and Partial Agonists Based on Eticlopride and the D₃R Crystal Structure: New Leads for Opioid Dependence Treatment

Vivek Kumar, Alessandro Bonifazi, Michael P. Ellenberger et al. · Journal of Medicinal Chemistry · 2016 · 89 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Evidence for Noncanonical Neurotransmitter Activation: Norepinephrine as a Dopamine D2-Like Receptor Agonist

Marta Sánchez‐Soto, Alessandro Bonifazi, Ning Cai et al. · Molecular Pharmacology · 2016 · 85 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17

Novel and High Affinity 2-[(Diphenylmethyl)sulfinyl]acetamide (Modafinil) Analogues as Atypical Dopamine Transporter Inhibitors

Jianjing Cao, Rachel D. Slack, Oluyomi M. Bakare et al. · Journal of Medicinal Chemistry · 2016 · 65 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Toward Understanding the Structural Basis of Partial Agonism at the Dopamine D₃Receptor

Mayako Michino, Comfort A. Boateng, Prashant Donthamsetti et al. · Journal of Medicinal Chemistry · 2016 · 60 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Novel Bivalent Ligands Based on the Sumanirole Pharmacophore Reveal Dopamine D₂ Receptor (D₂R) Biased Agonism

Alessandro Bonifazi, Hideaki Yano, Michael P. Ellenberger et al. · Journal of Medicinal Chemistry · 2017 · 53 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17